Boston, MA -- (SBWIRE) -- 08/27/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (AK Steel Holding Corporation(NYSE:AKS), Magnum Hunter Resources Corp (NYSE:MHR), Organovo Holdings Inc (NYSEMKT:ONVO), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
AK Steel Holding Corporation(NYSE:AKS) shares fell 0.56% to $3.53. The company on August 21 said that it has reached an agreement to settle an action brought on behalf of the U.S. Environmental Protection Agency and Commonwealth of Kentucky under the Clean Air Act and other statutes and regulations with respect to AK Steel's former Ashland, Kentucky coke plant. The agreement was reached without admission of the alleged violations by AK Steel.
Additionally, the company on August 16 said that members of the United Steelworkers (USW) Local 1865 union have ratified an 18-month labor agreement covering more than 800 hourly production and maintenance steel operations employees at the company's Ashland (KY) Works.
How Should Investors Trade AKS After The Recent Volatility? Get Free Report Here
Magnum Hunter Resources Corp (NYSE:MHR) shares increased 1.48% to $4.79. The company on August 26 announced that its Board of Directors has declared a dividend in the form of warrants to purchase shares of the Company's common stock at $8.50 per share. The warrants will be issued on October 15, 2013 to shareholders of record on September 16, 2013. Each shareholder of the Company's common stock will receive one warrant for every ten shares owned as of the record date (with the number of warrants rounded down to the nearest whole number).
How Should Investors Trade MHR After The Recent Volatility? Get Free Report Here
Organovo Holdings Inc (NYSEMKT:ONVO) stock is trading at $5.91. The company on August 12 reported on its financial results for the three-month period ended June 30, 2013 and provides a business update. For the three months ended June 30, 2013, total revenues of approximately $0.1 million were $0.2 million or 67% below the approximately $0.3 million in revenues for the same period in 2012. The Company also had negative cash flow from operations of $2.7 million during the three months ended June 30, 2013, with end-of-period cash and cash equivalents of approximately $12.8 million and an accumulated deficit of $70.1 million.
Is ONVO A Good Buy After The Recent Price Movement? Find Out Here
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares decreased 4.74% to $6.49. Analysts at Wells Fargo & Co. initiated coverage on shares of BCRX in a research report issued to clients and investors on August 23. The firm set an “outperform” rating and a $9.00 price target on the stock.
Additionally, the company, on August 5, announced that the underwriters of its recent public offering of its common stock have exercised in full their option to purchase an additional 600,000 shares. The total gross proceeds from this offering to BioCryst, including from the exercise of the over-allotment option, are expected to be $20.2 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by BioCryst.
Is BCRX A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)